🇺🇸 US

WST revenue, net income and debt history (West Pharmaceutical Services, Inc.)

Quick answer

West Pharmaceutical Services, Inc. (WST) reported revenue of $3.07B and net income of $493.7M for the fiscal year ended 2025-12-31, up 6.3% from $2.89B the year before, per its 10-K filed with the SEC on 2026-02-17. Long-term debt stood at $202.8M.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Fiscal yearRevenueNet incomeLong-term debt
2025 (FY ending 2025-12-31)$3.07B$493.7M$202.8M
2024 (FY ending 2024-12-31)$2.89B$492.7M$202.6M
2023 (FY ending 2023-12-31)$2.95B$593.4M$206.8M
2022 (FY ending 2022-12-31)$2.89B$585.9M$208.9M
2021 (FY ending 2021-12-31)$2.83B$661.8M$253.0M
2020 (FY ending 2020-12-31)$2.15B$346.2M$255.2M
2019 (FY ending 2019-12-31)$1.84B$241.7M$257.3M
2018 (FY ending 2018-12-31)$1.72B$206.9M$196.1M
2017 (FY ending 2017-12-31)$1.60B—$197.0M
2016 (FY ending 2016-12-31)$1.51B—$228.6M

Related

Last updated 2026-10-16. Data only, not financial or tax advice.